Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

BACKGROUND: There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends di...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gerontol A Biol Sci Med Sci
Autori principali: McNeil, John J, Woods, Robyn L, Nelson, Mark R, Murray, Anne M, Reid, Christopher M, Kirpach, Brenda, Storey, Elsdon, Shah, Raj C, Wolfe, Rory S, Tonkin, Andrew M, Newman, Anne B, Williamson, Jeff D, Lockery, Jessica E, Margolis, Karen L, Ernst, Michael E, Abhayaratna, Walter P, Stocks, Nigel, Fitzgerald, Sharyn M, Trevaks, Ruth E, Orchard, Suzanne G, Beilin, Lawrence J, Donnan, Geoffrey A, Gibbs, Peter, Johnston, Colin I, Grimm, Richard H
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
The Journal of Gerontology: Medical Sciences
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861878/
https://ncbi.nlm.nih.gov/pubmed/28329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gerona/glw342
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi